Dr Reddy's Laboratories to participate in PIVP

Hyderabad, Apr 17 (UNI) Dr Reddy's Laboratories Ltd today announced that it has signed on as the first participant in United States Pharmacopoeia's (USP) Pharmaceutical Ingredient Verification Programme(PIVP).

Participating in this programme shows that Dr Reddy's Laboratories shares USP's commitment to good pharmaceutical care throughout the world, said Dr Roger Williams, Chief Executive Officer and Executive Vice-President of USP in a statement.

''We look forward to participating in this programme so that we can show manufacturers, regulatory authorities and consumers our dedication to producing pharmaceutical ingredients that are of consistently high quality,'' said Satish Reddy, Chief Operating Officer and Managing Director of Dr Reddy's Laboratories Ltd.

The USP created the PIVP in response to increasing concerns throughout the pharmaceutical industry about the quality and consistency of pharmaceutical ingredients. The programme would enable the manufacturers to show the quality and integrity of their ingredients with a recognisable 'USP Verified' mark.

UNI